2026-04-28T22:57:01Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/232012024-11-28T22:10:21Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967

00925njm 22002777a 4500 dc Verd, Sergio author Verd, Mateo author 2021-01-26 Verd S, Verd M. Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? [editorial]. Front Pharmacol. 2021 Jan 26;11:625295. 1663-9812 http://hdl.handle.net/20.500.13003/9109 https://hdl.handle.net/20.500.12105/23201 33574761 10.3389/fphar.2020.625295 Frontiers in Pharmacology 2-s2.0-85101030519 615977200001 L634131245 Metabolic syndrome Obesity Down syndrome Oxidative stress Hyperthyroidism Glutathione Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?